Pharmabiz

Labcorp, US FDA and Charles River announce research collaboration to advance preclinical methods for evaluating drug abuse potential

Labcorp, US FDA and Charles River announce research collaboration to advance preclinical methods for evaluating drug abuse potential: Burlington, North Carolina Saturday, October ...
Pharmabiz

China approves Enhertu as first and only tumour agnostic HER2 directed medicine and ADC for previously treated patients with HER2 positive metastatic solid tumours

China approves Enhertu as first and only tumour agnostic HER2 directed medicine and ADC for previously treated patients with HER2 positive metastatic solid tumours: Tokyo Saturday ...
Pharmabiz

Otsuka presents final phase 3 VISIONARY results at ASN demonstrating Voyxact stabilized kidney function and reduced risk of disease progression and kidney failure

Otsuka presents final phase 3 VISIONARY results at ASN demonstrating Voyxact stabilized kidney function and reduced risk of disease progression and kidney failure: Princeton, New ...
Pharmabiz

China NMPA approves Harbour BioMed’s BLA for batoclimab injection to treat generalized myasthenia gravis

China NMPA approves Harbour BioMed’s BLA for batoclimab injection to treat generalized myasthenia gravis: Cambridge, Massachusetts Saturday, October 24, 2026, 17:00 Hrs [IST] Ha ...